Hyperaldosteronism
📧 Sign up to get email alerts when something new happens for Hyperaldosteronism.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-14EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
EMA has authorized Qaialdo, a spironolactone product by Lipomed GmbH, for several conditions including edema, heart failure, liver cirrhosis…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism [Phase 3]
This Phase 3 clinical trial is evaluating the efficacy and safety of Baxdrostat in participants with primary hyperaldosteronism. The study i…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction [NA]
A completed clinical trial evaluating a novel pacemaker algorithm for diagnosing sleep apnea and its relationship with aldosterone levels in…
-
EMA approval · 2026-03-24EMA Authorised: Qaialdo (spironolactone) — Lipomed GmbH
Qaialdo is a spironolactone product by Lipomed GmbH that has been authorized in the EU. Indications include edema, heart failure, liver cirr…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Study of CIN-107 in Adults With Primary Aldosteronism [Phase 2]
Phase 2 clinical trial of CIN-107 in adults with primary aldosteronism completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism [NA]
A clinical trial compares superselective adrenal arterial embolization to oral spironolactone for idiopathic hyperaldosteronism. The study i…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) [NA]
This entry describes the TARGET-PA trial evaluating an aldosterone-hybrid steroid to guide curable treatment of primary aldosteronism; the s…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions
Clinical trial update on recruiting for a study evaluating endoscopic ultrasound-guided radiofrequency ablation of upper gastrointestinal tr…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism [Phase 2]
Phase 2 clinical trial evaluating [68Ga]Ga-PentixaFor PET imaging to assess adrenal gland function in hyperaldosteronism and hypercortisolis…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: CHina Adrenal Venous saMPling InvestigatiON
Clinical trial update from China on adrenal venous sampling to study hyperaldosteronism; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Tissue K+ in Primary Hyperaldosteronism
A clinical trial investigating tissue potassium in primary hyperaldosteronism has completed, sponsored by the University of Erlangen-Nürnber…
-
FDA approval · 2025-11-14FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Aldactone (spironolactone) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Adrenal Tumors - Pathogenesis and Therapy
This clinical trial update indicates that a study on the pathogenesis and therapy of adrenal tumors is currently recruiting, covering condit…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Is the Evolution of the Aldosterone-renin Ratio Pre- Versus Post-operative on Day 1 Following Unilateral Adrenalectomy for Primary Hyperaldosteronism Predictive of Blood Pressure Outcomes
This ClinicalTrials.gov entry describes a study investigating whether the aldosterone-renin ratio before versus after unilateral adrenalecto…
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment [NA]
Göteborg University-sponsored clinical trial comparing mineralocorticoid receptor antagonists versus surgical treatment for unilateral prima…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism
A completed trial indicates that metomidate PET-CT more accurately predicts outcomes after adrenalectomy than adrenal venous sampling in pat…
-
FDA approval · 2025-02-21FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for spironolactone, establishing a generic version of the diuretic. Spironolac…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension [NA]
A clinical trial update on an electronic alert designed to improve screening for primary aldosteronism in patients with hypertension.
-
FDA approval · 2025-01-23FDA Approved: SPIRONOLACTONE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original application for spironolactone (generic) from Rising Pharma Holdings, Inc., authorizing the marketing of a gen…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)
The HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I.) trial is currently active but not recruiting, per the sponsor Université …
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Primary Aldosteronism in Western Norway
This clinical trial update notes a study in Western Norway focusing on primary hyperaldosteronism, currently recruiting.
-
CLINICAL_TRIALS other · 2024-10-18Clinical Trial Update: Effects of Sleep Body Temperature on Body Composition [NA]
Clinical trial update for 'Effects of Sleep Body Temperature on Body Composition' showing not yet recruiting; sponsor is Jinan University Gu…
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
A study update from Haukeland University Hospital on dynamic hormone profiling and multimodal data capture in primary aldosteronism and rela…
-
CLINICAL_TRIALS withdrawal · 2024-05-10Clinical Trial Update: Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.
Clinical trial NCT04556279 investigating salt taste thresholds in patients with primary hyperaldosteronism before and after treatment has be…